Related Experiment Video
Updated: Mar 2, 2026
Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
Published on: March 25, 2015
siRNA-nanoparticle conjugate in gene silencing: A future cure to deadly diseases?
Rituparna Acharya1, Suman Saha2, Sayantan Ray2
1Jadavpur University, 188, Raja S.C.Mullick Road, Kolkata 700 032, India.
Abstract:
Alzheimers, cancer, acquired immune deficiency syndrome (AIDS) are considered to be some of the most deadly diseases of the 21st century on account of their severity and rapid increase in the number of affected population and with scarce cases of recovery, they still remain a troubling paradox. Specifically, with millions of cancer patients worldwide and lack of proper cure for the same, understanding the deadly disease at the molecular level and planning a therapeutic strategy in the same line is the need of the hour. Further, the potential threat of prevalence and escalation of Alzheimer's and HIV (human immunodeficiency virus) infection by more than three times as of recent past, needs a medical breakthrough to arrive at a meaningful solution to tackle the present day scenario. It is evident that these diseases initiate and propagate based on certain genes and their expression which needs to be silenced by the help of small interfering RNA (siRNA) by at least 70%. For short term silencing of the protein coding genes, siRNA is the most appropriate tool. Hence, the present communication explores the possibility for treatment and cure of a plethora of deadly diseases, e.g., cancer, including Alzheimer's and AIDS to some extent, emphatically at the molecular level, using the current trend of RNAi (RNA interference) delivery via a wide variety of nanoparticles.
Insights
Small interfering RNA (siRNA) delivered via nanoparticles offers a promising therapeutic strategy for silencing disease-causing genes. This approach targets deadly diseases like cancer, Alzheimer's, and AIDS at the molecular level for potential treatment and cure.
Area of Science:
- Molecular Biology
- Nanotechnology
- Genetics
Background:
- Deadly diseases such as cancer, Alzheimer's, and acquired immune deficiency syndrome (AIDS) pose significant global health challenges with limited recovery rates.
- Understanding these diseases at a molecular level is crucial for developing effective therapeutic strategies.
- The increasing prevalence of Alzheimer's and human immunodeficiency virus (HIV) necessitates urgent medical breakthroughs.
Purpose of the Study:
- To explore the potential of RNA interference (RNAi) using small interfering RNA (siRNA) for treating complex diseases.
- To investigate the use of various nanoparticles for efficient siRNA delivery.
- To target gene expression at a molecular level for therapeutic intervention.
Main Methods:
- Utilizing small interfering RNA (siRNA) to silence specific protein-coding genes.
- Employing RNA interference (RNAi) as a gene-silencing mechanism.
- Developing and applying nanoparticle-based delivery systems for siRNA.
Main Results:
- Small interfering RNA (siRNA) demonstrates potential for short-term silencing of protein-coding genes.
- Nanoparticle delivery systems are explored for effective RNAi-based gene silencing.
- The study investigates the application of this technology for diseases including cancer, Alzheimer's, and AIDS.
Conclusions:
- RNAi mediated by siRNA delivered via nanoparticles presents a novel therapeutic avenue for intractable diseases.
- Targeting gene expression offers a molecular strategy to combat conditions like cancer, Alzheimer's, and AIDS.
- Further research into nanoparticle-mediated siRNA delivery could lead to significant advancements in disease treatment.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
02:15Experimental RNAi
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
00:59Gene Therapy
01:59CRISPR
02:30Small interfering RNAs (siRNA)